Parker-Hannifin Keeps Delivering. But Investors are Paying a Premium

Parker-Hannifin Corporation (NYSE:PH) is not attractive simply because it is a large industrial company. What really sets it apart is the kind of products it makes and the role those products play for customers. Its components are often small pieces of much larger systems, but they can be critical to keeping those systems running.

That gives Parker a business advantage that is not easy to replicate. The question now is whether the stock price has already priced in too much of that strength.

Parker-Hannifin’s Moat

Parker-Hannifin Corporation sells motion and control products to a wide range of industries, including aerospace, industrial equipment, transportation, energy and HVAC. In many cases, customers are not going to replace a Parker component just because another supplier offers something a little cheaper. For a broader look at companies positioned to benefit from this shift, see 10 Best Industrial Automation Stocks to Buy Now

There is a reason for that. Once a component is built into an aircraft, machine, or industrial system, changing suppliers can take time and money. Products may have to be tested again, systems may need to be requalified, and engineers may have to make changes. For customers, that can create more hassle than the potential savings are worth. Parker’s size helps, too. The company has a huge product portfolio and decades of engineering experience behind it. Smaller competitors may be able to compete on individual products, but matching Parker across so many different applications is a much bigger challenge.

Acquisitions have become another important part of the story. Parker has spent years buying businesses that can improve its margins and give it more exposure to attractive markets and aftermarket demand. The pending Filtration Group and CIRCOR Aerospace deals should add to that portfolio.

The latest numbers suggest the strategy is still delivering. Sales rose 9.8% to a record $5.8 billion in the fourth quarter of fiscal 2026, while adjusted EPS jumped 21% to $9.27. Organic sales were up 8%, and adjusted segment operating margin reached 28%.

Industry Trends Remain Favorable

Parker is also operating in several markets that have good long-term growth potential. Aerospace is one of the biggest opportunities. Aircraft manufacturers and suppliers are working through strong demand, while older fleets also need parts and maintenance. Parker’s Aerospace Systems segment grew organic sales by 13.3% in the latest quarter, and orders increased 18%. Management expects another 7% to 10% of organic sales growth from the segment in fiscal 2027.

There are opportunities outside aerospace as well. Electrification, automation, and upgrades to aging industrial infrastructure should all create demand for Parker’s products over time. The company expects overall organic sales growth of 5.5% to 8.5% in fiscal 2027, with adjusted EPS of $34.25 to $35.25.That is a fairly good setup for an industrial company. Parker is getting some help from the recovery in cyclical markets, but it is also tied to trends that could remain relevant for years.

Dividend Yield Is Small, but the Growth Matters

Parker-Hannifin Corporation is not going to appeal to investors looking for a big dividend check today. Its dividend yield is only around 0.8% at the current share price. The track record is a different story. Parker raised its quarterly dividend by 11% to $2.00 per share in 2026, taking the annual payout to $8. The company has now increased its dividend for 70 straight fiscal years and has paid 305 consecutive quarterly dividends. There are seven stocks that rank higher than PH in our Dividend Kings list. 

The low yield is partly a reflection of how much the stock has appreciated. More importantly, Parker does not need to devote a huge portion of its earnings to the dividend. Adjusted EPS was $32.31 in fiscal 2026, putting the payout ratio at roughly 25%. That leaves plenty of room for the dividend to grow if earnings and cash flow keep moving in the right direction. Another stock has achieved the feat of increasing dividends for 70 consecutive years.

The Stock Is Expensive

The biggest issue with Parker-Hannifin Corporation today is not the business. It is the price investors are being asked to pay for it. The stock’s trailing P/E sits at 33.88x and its forward P/E at 27.47x. The lower forward multiple makes sense because earnings are expected to increase.

Still, a forward P/E close to 28x is not cheap for an industrial stock. At that multiple, Parker’s forward earnings yield is only about 3.6%. The trailing earnings yield is even lower, at roughly 3.0%. Investors are therefore paying a significant premium today in exchange for the expectation that future earnings will be meaningfully higher.

That premium has become much larger over time. Parker’s forward P/E was generally in the mid-teens to low-20s in earlier periods. It climbed to 24.29x in fiscal 2025 and 28.47x in fiscal 2026. There is also a difference between the market’s earnings expectations and Parker’s own guidance. Management expects fiscal 2027 adjusted EPS of $34.25 to $35.25, with a midpoint of $34.75. At the current share price, that would put the stock at roughly 30x management’s earnings forecast. That is a demanding valuation.

The Bottom Line

There is a lot to like about Parker-Hannifin. The company sells products that customers depend on, has built deep engineering expertise, and has a long history of using acquisitions to improve the business. Aerospace and other industrial markets could provide another leg of growth, while the dividend has an unusually strong track record.

However, a great business does not automatically make a great stock at any price. Parker is already valued as a high-quality compounder. With the forward P/E in the high-20s and potentially around 30x based on management’s own fiscal 2027 guidance, investors have limited room for weaker-than-expected results. The business looks strong. The valuation is the part that deserves more caution.

READ NEXT: Jim Cramer Says This Stock Could Rise Like Moderna (MRNA) and Jim Cramer Says StandardAero (SARO) Stock Comes With a Downside Catch 

This article is originally published at Insider Monkey.